Price (GBX)
5.65 -% (-)
Track 1 instrument
Open / Last close
- / 5.65
High / Low
6.00 / 5.65
Bid / Offer
5.50 / 5.80
Special Condition: -
Trading Status: Regular Trading
As at 22.09.20 08:45:42 - All data delayed at least 15 minutes

Arena Events Group PLC instruments

Select instrument to view
Equity (1)
Code Instrument name Price Change Type Documentation

Price information

What's this?
Open price
Previous close price / date
5.65 / 21 September 2020
52 week range
4.50 / 27.00
YTD return
1 year return

Instrument information

What's this?
Instrument market cap (£m)
Earnings per share
Issue date
25 July 2017
Market identifier code (MIC)
Country of share register
Market segment
Trading service
Nominated Advisers
Date Time Price CurrencyVolume Trade ValueTrade type Trade flag MIC
22.09.20 08:33:29 5.53 GBX 3,995 220.72 Off-Book - AIMX
21.09.20 16:10:53 5.53 GBX 34,878 1,927.01 Off-Book N AIMX
21.09.20 15:31:37 5.53 GBX 100 5.53 Off-Book N AIMX
21.09.20 15:27:39 5.53 GBX 16,515 912.45 Off-Book N AIMX
21.09.20 12:06:20 5.53 GBX 22,459 1,240.86 Off-Book N AIMX

Equity Research

from Arena Events Group PLC
Cenkos: Arena Events -- FY20A Results

Whilst Arena delivered FY20E results in line with our expectations, this has inevitably been overshadowed by the challenges posed by COVID-19 to the industry. Arena acted swiftly to cut costs and preserve cash, such that it currently has a c£23.5m cash balance. This is enough to see the company thro ...

View report
Cenkos: Arena Events Group Plc -- Equity placing to fortify the balance sheet

Arena's planned £9.5m share placing will substantially strengthen its balance sheet and, together with various cost saving measures being undertaken, should help to see the company through the coronavirus crisis for the foreseeable future. Given the uncertainty around how long it will take before no ...

View report
Cenkos: Arena Events Group Plc -- Interim results

Despite the challenging market environment, Arena has delivered interim results that were broadly in line with our expectations (Adj EBITDA of £16.6m vs £17.0m forecasted). Cost saving initiatives are being implemented, which should support margins going forwards, whilst the company is expected to b ...

View report
Small Cap Feast

AMRYT PHARMA PLC— a biopharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of patients with rare or orphan diseases have raised $60m before expenses and will relist on the AIM Market on the 25/09/2019. VAALCO Energy, Inc. (NYSE: EGY), an in ...

View report
Cenkos: Arena Events Group Plc - H1/19A Interim Results

Arena's interim results showed strong revenue growth, driven primarily by acquisitions, along with modest LFL growth. We expect a strong performance in the Middle East to be offset by a more challenging environment in the UK and the US, leading us to revise our forecasts downwards.

View report

Latest reports

from Arena Events Group PLC
Admission Document
Issuer presentations live and on demand
Watch on Spark Live